Survival in thalassaemia major patients - Prognostic value of doppler-demonstrated left ventricular restrictive filling pattern

Circulation Journal

Volumn 70, Issue 8, 2006, Pages 1037-1042

  Efthimiadis, Georgios K ^a   Hassapopoulou, Helen P ^b   Tsikaderis, Dimitrios D ^a   Karvounis, Haralambos I ^a   Giannakoulas, Georgios A ^a   Parharidis, Georgios E ^a   Louridas, Georgios E ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b AHEPA UNIVERSITY HOSPITAL   (Greece)

Author keywords

Cardiac mortality; Doppler echocardiography; Left ventricular restrictive filling pattern; Thalassaemia major

Indexed keywords

DEFEROXAMINE MESYLATE; FERRITIN;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD TRANSFUSION; CHELATION THERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DOPPLER ECHOCARDIOGRAPHY; FEMALE; FERRITIN BLOOD LEVEL; HEART DEATH; HEART LEFT VENTRICLE CONTRACTION; HEART LEFT VENTRICLE FILLING; HEART LEFT VENTRICLE RESTRICTIVE FILLING PATTERN; HEMATOLOGICAL PARAMETERS; HUMAN; IRON CHELATION; LONGITUDINAL STUDY; MALE; MORTALITY; OBSERVATIONAL STUDY; OVERALL SURVIVAL; PATIENT COMPLIANCE; PREDICTION; PROGNOSIS; SURVIVAL RATE; THALASSEMIA MAJOR;

ADOLESCENT; ADULT; BETA-THALASSEMIA; CHELATION THERAPY; DEATH; DEFEROXAMINE; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; SIDEROPHORES; SURVIVAL ANALYSIS; SURVIVAL RATE; VENTRICULAR DYSFUNCTION, LEFT;

EID: 33746671279     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.70.1037     Document Type: Article

References (29)

1. Engle MA, Erlandson M, Smith CH. Late cardiac complications of chronic, severe, refractory anemia with hemochromatosis. Circulation 1964; 30: 698-705.
2. Ehlers KH, Levin AR, Markenson AL, Marcus JR, Klein AA, Hilgartner MW, et al. Longitudinal study of cardiac function in thalassemia major. Ann NY Acad Sci 1980; 344: 397-404.
3. Brittenham GM, Griffith PM, Nienhuis AW, McLaren CE, Young NS, Tucker EE, et al. Efficacy of deferoxamine in preventing complications of iron overload in patients with thalassemia major. N Engl J Med 1994; 331: 567-573.
4. Olivieri NF, Nathan DG, MacMillan JH, Wayne AS, Liu PP, McGee A, et al. Survival in medically treated patients with homozygous beta-thalassemia. N Engl J Med 1994; 331: 574-578.
5. Spirito P, Lupi G, Melevendi C, Vecchio C. Restrictive diastolic abnormalities identified by Doppler echocardiography in patients with thalassemia major. Circulation 1990; 82: 88-94.
6. Kremastinos DT, Tsiapras DP, Tsetsos GA, Rentoukas EI, Vretou HP, Toutouzas PK. Left ventricular diastolic Doppler characteristics in beta-thalassemia major. Circulation 1993; 88: 1127-1135.
7. Kremastinos DT, Tiniakos G, Theodorakis GN, Katritsis DG, Toutouzas PK. Myocarditis in beta-thalassemia major: A cause of heart failure. Circulation 1995; 91: 66-71.
8. Appleton CP, Hatle LK, Popp RL. Demonstration of restrictive ventricular physiology by Doppler echocardiography. J Am Coll Cardiol 1988; 11: 757-768.
9. Nishimura RA, Tajik AJ. Evaluation of diastolic filling of left ventricle in health and disease: Doppler echocardiography is the clinician's Rosetta Stone. J Am Coll Cardiol 1997; 30: 8-18.
10. Xie GY, Berk MR, Smith MD, Gurley JC, DeMaria AN. Prognostic value of Doppler transmitral flow patterns in patients with congestive heart failure. J Am Coll Cardiol 1994; 24: 132-139.
11. Rihal CS, Nishimura RA, Hatle LK, Bailey KR, Tajik AJ. Systolic and diastolic dysfunction in patients with clinical diagnosis of dilated cardiomyopathy: Relation to symptoms and prognosis. Circulation 1994; 90: 2772-2779.
12. Pinamonti B, Di Lenarda A, Sinagra G, Camerini F. Restrictive left ventricular filling pattern in dilated cardiomyopathy assessed by Doppler echocardiography: Clinical, echocardiographic and hemodynamic correlations and prognostic implications (Heart Muscle Disease Study Group). J Am Coll Cardiol 1993; 22: 808-815.
13. Yu HC, Sanderson JE. Different prognostic significance of right and left ventricular diastolic dysfunction in heart failure. Clin Cardiol 1999; 22: 504-512.
14. Sahn DJ, DeMaria A, Kisslo J, Weyman A. Recommendations regarding quantitation in M-mode echocardiography: Results of a survey of echocardiographic measurements. Circulation 1978; 58: 1072-1083.
15. Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, et al. Echocardiographic assessment of left ventricular hypertrophy: Comparison to necropsy findings. Am J Cardiol 1986; 57: 450-458.
16. Romhilt DW, Estes EH Jr. A point-score system for the ECG diagnosis of left ventricular hypertrophy. Am Heart J 1968; 75: 752-758.
17. Du ZD, Roguin N, Milgram E, Saab K, Koren A. Pulmonary hypertensionin patients with thalassemia major. Am Heart J 1997; 134: 532-537.
18. Kremastinos DT, Rentoukas E, Mavrogeni S, Kyriakides ZS, Politis C, Toutouzas P. Left ventricular filling pattern in beta-thalassaemia major - a Doppler echocardiographic study. Eur Heart J 1993; 14: 351-357.
19. Karvounis HI, Zaglavara TA, Parharidis GE, Nouskas IG, Hassapopoulou EP, Gemitzis KD, et al. An angiotensin-converting enzyme inhibitor improves left ventricular systolic and diastolic function in transfusion-dependent patients with beta-thalassemia major. Am Heart J 2001; 141: 281.
20. Hou JW, Wu MH, Lin KH, Lue HC. Prognostic significance of left ventricular diastolic indexes in beta-thalassemia major. Arch Pediatr Adolesc Med 1994; 148: 862-866.
21. Olivieri NF, Brittenham GM. Iron-chelating therapy and the treatment of thalassemia. Blood 1997; 89: 739-761.
22. Modell B, Letsky EA, Flynn DM, Peto R, Weatherall DJ. Survival and desferrioxamine in thalassaemia major. BMJ (Clin Res Ed) 1982; 284: 1081-1084.
23. Wolfe L, Olivieri N, Sallan D, Colan S, Rose V, Propper R, et al. Prevention of cardiac disease by subcutaneous deferoxamine in patients with thalassemia major. N Engl J Med 1985; 312: 1600-1603.
24. Desideri A, Scattolin G, Gabellini A, Cavuto F, Vanzelli M, Formichi M, et al. Left ventricular function in thalassemia major: Protective effect of deferoxamine. Can J Cardiol 1994; 10: 93- 96.
25. Kitabatake A, Inoue M, Asao M, Tanouchi J, Masuyama T, Abe H, et al. Transmitral blood flow reflecting diastolic behavior of the left ventricle in health and disease: A study by pulsed Doppler technique. Jpn Circ J 1982; 46: 92-102.
26. Oh JK, Appleton CP, Hatle LK, Nishimura RA, Seward JB, Tajik AJ. The noninvasive assessment of left ventricular diastolic function with two-dimensional and Doppler echocardiography. J Am Soc Echocardiogr 1997; 10: 246-270.
27. Appleton CP, Jensen JL, Hatle LK, Oh JK. Doppler evaluation of left and right ventricular diastolic function: A technical guide for obtaining optimal flow velocity recordings. J Am Soc Echocardiogr 1997; 10: 271-292.
28. Vogel M, Anderson LJ, Holden S, Deanfield JE, Pennell DJ, Walker JM. Tissue Doppler echocardiography in patients with thalassaemia detects early myocardial dysfunction related to myocardial iron overload. Eur Heart J 2003; 24: 113-119.
29. Iarussi D, Di Salvo G, Pergola V, Coppolino P, Tedesco MA, Ratti G, et al. Pulsed Doppler tissue imaging and myocardial function in thalassemia major. Heart Vessels 2003; 18: 1-6.